Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 528 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

NCT02081378

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
Locations
  • Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University SC-6 Portland, Oregon, United States
View all 18 locations
View Trial Details
Completed

PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit

NCT04767802

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Hospital Sultanah Aminah Johor Bahru, Johor, Malaysia
  • Hospital Raja Perempuan Zainab Kota Bharu, Kelantan, Malaysia
  • Hospital Raja Permaisuki Bainun Ipoh, Perak, Malaysia
  • Hospital Umum Sarawak Kuching, Sarawak, Malaysia
View Trial Details
Completed

The EMPATHY Pilot Study

NCT04384848

Conditions
Bone Marrow Diseases, Cancer, Chronic Disease, +12 more
Locations
  • Augusta University, Hematology and Oncology Augusta, Georgia, United States
  • Northwestern University, Robert H. Lurie Comprehensive Cancer Center Comprehensive Cancer Center (RHLCCC) Chicago, Illinois, United States
  • Policlinico Sant'Orsola Malpighi - UOC Ematologia - Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO - Azienda Ospedaliera G. Brotzu Cagliari, Italy
View all 16 locations
View Trial Details
Completed

Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5q

NCT01081431

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus an der TU Dresden Dresden, Germany
  • Kath. Klinikum Duisburg Duisburg, Germany
  • Heinrich Heine Universität Düsseldorf Düsseldorf, Germany
View Trial Details
Completed

Effect of 2nd Gen TKI in CML

NCT02222272

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Rigshospitalet Copenhagen, Denmark
  • Helsinki University Central Hospital Helsinki, Finland
  • University of Freiburg Freiburg im Breisgau, Germany
  • University of Muenster Münster, Germany
View Trial Details
Completed

Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant

NCT01812252

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Kaiser Permanente Washington Seattle, Washington, United States
View Trial Details

Related conditions